Delivery Order SPE2DR25D1047-SPE2DR26F24C3
- Not listed
- The Defense Logistics Agency awarded a $2,474.42 firm fixed price delivery order (4570030274) to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of November 18, 2025. This competitively awarded, non-set-aside contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled...
- The Defense Logistics Agency awarded a $11,522.88 delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of May 2, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis with no set-aside designation. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on November 6, 2025, with a ceiling value of $1,092.57. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made on a competitive, non-set-aside basis and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $2,197.63 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger contract vehicle with the...
- The Defense Logistics Agency awarded a $2,259.24 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $5,067.89 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $2,093.98 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This firm fixed-price contract was competitively awarded without set-aside designations and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance in Conshohocken, Pennsylvania and completion by July 23, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing typical of DLA pharmaceutical procurement. Valtoco is a rescue medication indicated for acute repetitive seizure episodes, reflecting the broad therapeutic scope of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,173.67 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance completion required by August 15, 2025. This firm fixed-price contract, awarded on August 14, 2025, represents a non-set-aside competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- SPE2DR25D1047Indefinite Delivery Contract
- SPE2DR25D1047-SPE2DR26F24C3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,407.74 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of December 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication used to treat acute repetitive seizure clusters in patients with epilepsy. This delivery order reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. As a major healthcare solutions provider, AmerisourceBergen maintains extensive federal contracting relationships with the DLA and Defense Health Agency, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/18/25 |